Trials / Terminated
TerminatedNCT00082563
Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum
A Phase II, Randomized, Comparative Trial Of Azithromycin In Combination With Chloroquine Versus Chloroquine In The Eradication Of Asymptomatic Plasmodium Falciparum Infection In Semi-Immune Adults
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if Azithromycin in combination with chloroquine is superior to chloroquine alone in eradicating P. falciparum asexual parasitemia in asymptomatic, semi-immune adults in Western Kenya.
Detailed description
The trial was terminated prematurely 9 November 2004 due to the inability to recruit the planned number of subjects. There were no safety or efficacy concerns regarding the study in the decision to terminate the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin/Chloroquine | |
| DRUG | Chloroquine |
Timeline
- Start date
- 2004-08-01
- Completion
- 2004-11-01
- First posted
- 2004-05-14
- Last updated
- 2011-04-26
Source: ClinicalTrials.gov record NCT00082563. Inclusion in this directory is not an endorsement.